A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
Learn more about:
Related Clinical Trial
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
Phase III Study of Telitacicept in Patients With IgA Nephropathy
Oxford Classification and Clinical Remission After Initial Treatments in Patients With IgA Nephropathy
TESTING -ON Post-Trial ObservatioNal Cohort Study
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject
Bortezomib for Treating Glomerular Diseases
Correlation of Microbiome and Metabonomics With IgA Nephropathy
A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy
Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)
Study of ALXN2050 in Proliferative Lupus Nephritis (LN) and Immunoglobulin A Nephropathy (IgAN)
A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy.
A Phase 2 Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
Steroids Therapy in IgA Nephropathy With Crescents
SodiUm Restriction by Behavioral Intevention
Atacicept in Subjects With IgA Nephropathy
Open-Label Extension Study of BION-1301 in IgA Nephropathy
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Atrasentan in Patients With Proteinuric Glomerular Diseases
Atrasentan in Patients With IgA Nephropathy
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy
Rituximab and RASi in Patients With IgAN
The Role of T/B Cell Repertoire in Non-invasive Diagnosis and Disease Monitoring in Patients With IgA Nephropathy
Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
First in Human Study to Assess Safety of VIS649 in Healthy Subjects
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Safety and Efficacy Study of VIS649 for IgA Nephropathy
Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation
Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy
A Study of RC18 Administered Subcutaneously to Subjects With IgA(Immunoglobulin A) Nephropathy
A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Study of Standardized Treatment of Integrative Medicine With the Severe IgA Nephropath
Aliskiren for Immunoglobulin A (IgA) Nephropathy
Steroids and Azathioprine in Advanced IgAN
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy
Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis
BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy
Paricalcitol for the Treatment of Immunoglobulin A Nephropathy
Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy
The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.
A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers
Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy
“Steroids and Azathioprine Versus Steroids Alone in IgAN”
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Pilot Study of Velcade® in IgA Nephropathy
Diet Intervention in Food Sensitive Patients With IgA Nephropathy
Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Biomarkers for the Progression of IgA Nephropathy
Oral Treatment With PL-56 in Patients With IgA Nephropathy – an Explorative Study
Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
Probiotics in IgA Nephropathy
The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients
Mycophenolate Mofetil for IgA Nephropathy
Extended Follow-up of Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy
Registry of IgA Nephropathy in Chinese Children
Treatment of IgA Nephropathy According to Renal Lesions
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration
IgA Nephropathy, Lymphocyte Homing and IgA Class Switch
Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)
Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy
Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy
Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy
Efficacy and Safety of Atacicept in IgA Nephropathy
Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy
Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy
Rituximab in Recurrent IgA Nephropathy
Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)
A Controlled Study of Uric Acid on the Progression of IgA Nephropathy
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy
Fecal Microbiota Transplantation for Refractory IgA Nephropathy
A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)